Rockwell Medical (RMTI) Change in Inventory (2010 - 2026)
Rockwell Medical (RMTI) posted Change in Inventory of -$369000.0 for Q1 2026, up 59.18% on a QoQ basis from -$904000.0 in Q4 2025, and up 49.66% year-over-year from -$246560.6 in Q1 2025.
Rockwell Medical (RMTI) Change in Inventory (2010 - 2026) Analysis & Trends
Rockwell Medical's Change in Inventory history runs 17 years deep, the most recent figure standing at -$369000.0 for Q1 2026.
- Quarterly Change in Inventory rose 49.66% year-over-year to -$369000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 300.5% YoY) and the FY2025 annual result came in at -$2.8 million, down 937.05% from the prior year.
- Change in Inventory was -$369000.0 for Q1 2026 at Rockwell Medical, up from -$904000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $1.5 million in Q1 2022 and bottomed at -$1.6 million in Q3 2023.
- A 5-year average of -$111235.3 and a median of -$190000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory soared 1056.86% — and 2025, when it plunged 90500.0%.
- Rockwell Medical's Change in Inventory stood at $1.2 million in 2022, then sank by 67.37% to $385000.0 in 2023, then sank by 99.74% to $1000.0 in 2024, then plunged by 90500.0% to -$904000.0 in 2025, then soared by 59.18% to -$369000.0 in 2026.
- Business Quant data shows RMTI's Change in Inventory at -$369000.0 in Q1 2026, -$904000.0 in Q4 2025, and -$257000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Rockwell Medical | 25.77 Mn | 1.88 Mn | 2.90 Mn | -369,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -369,000.00 |
| Mar 31, 2026 | -369,000.00 |
| Dec 31, 2025 | -904,000.00 |
| Dec 31, 2025 | -904,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Sep 30, 2025 | -257,000.00 |
| Jun 30, 2025 | -885,000.00 |
| Jun 30, 2025 | -885,000.00 |
| Mar 31, 2025 | -733,000.00 |
| Mar 31, 2025 | -733,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Sep 30, 2024 | 319,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Jun 30, 2024 | -190,000.00 |
| Mar 31, 2024 | 202,000.00 |
| Mar 31, 2024 | 202,000.00 |
| Dec 31, 2023 | 385,000.00 |
| Dec 31, 2023 | 385,000.00 |